A genome-wide meta-analysis reveals shared and population-specific variants for allergic sensitization
- PMID: 39644933
- DOI: 10.1016/j.jaci.2024.11.033
A genome-wide meta-analysis reveals shared and population-specific variants for allergic sensitization
Abstract
Background: Allergic diseases are major causes of morbidity in both developed and developing countries and represent a global burden on health care systems. Allergic sensitization is defined as the production of IgE specific to common environmental allergens and is an important indicator in the assessment of allergic diseases.
Objective: We sought to clarify the genetic basis of allergic sensitization.
Methods: We performed a genome-wide association study (GWAS) of allergic sensitization in the Japanese population followed by a cross-ancestry meta-analysis with a European population including 20,492 cases and 23,342 controls for Japanese and 8,246 cases and 16,786 controls for Europeans. We also performed a polysensitization GWAS of a Japanese population including 4,923 cases and 17,009 controls.
Results: Allergic sensitization GWAS identified 18 susceptibility loci for Japanese only and 23 loci for the cross-ancestry population, among which 4 loci were novel. Polysensitization GWAS identified 8 significant loci. Expression quantitative trait locus colocalization analysis revealed polysensitization GWAS significant variants affecting both the phenotype and the expression of the CD28, LPP, and LRCC32 genes. Cross-population genetic correlation analysis of allergic sensitization suggested that heterogeneity exists in allergic sensitization between Europeans and Japanese, indicating that more genetic heterogeneity may exist in allergic sensitization than allergic diseases.
Conclusions: Our investigation provides new insights into the molecular mechanism of allergic sensitization that could enhance current understanding of allergy and allergic diseases.
Keywords: Allergic sensitization; colocalization; eQTL; genome-wide association study; polysensitization GWAS.
Copyright © 2024 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure statement This work was supported by the Japan Society for the Promotion of Science (JSPS) (grant nos. 21J11802 and 23H03143), a Grant-in-Aid for JSPS Fellows, and the Japan Agency for Medical Research and Development (grant nos. JP20ek0410076 and JP21tm0424601). The Japanese reference panel used for whole-genome imputation in this study was obtained from BioBank Japan and the 1000 Genomes Project Phase 3 (v5) through the National Bioscience Database Center/Japan Science and Technology Agency. The Japanese reference panel used for HLA imputation was obtained from National Bioscience Database Center. The data used for the analyses described in this article were obtained from ImmuNexUT and the GTEx portal. Samples, cohort information, and genome data of TMM biobank were provided by the TMM Project (research number: 2018-0040). This study was supported in part by the TMM Project, which is supported by the Ministry of Education, Culture, Sports, Sciences and Technology of Japan and the Japan Agency for Medical Research and Development. The GTEx Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by the National Cancer Institute, National Human Genome Research Institute, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Institute of Mental Health, and National Institute of Neurological Disorders and Stroke. Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
